GLS Pharma Limited — Cyclophosphamide Exporter Profile
Indian Pharmaceutical Exporter · #12 for Cyclophosphamide · $120.3K export value · DGFT Verified
GLS Pharma Limited is the #12 Indian exporter of Cyclophosphamide with $120.3K in export value and 32 verified shipments. GLS Pharma Limited holds a 0.6% market share in Cyclophosphamide exports across 5 countries. The company exports 4 pharmaceutical products worth $198.8K across 2 therapeutic categories.
GLS Pharma Limited — Cyclophosphamide Export Profile: Buyers & Destinations
Where Does GLS Pharma Limited Export Cyclophosphamide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MEXICO | $107.3K | 23 | 89.2% |
| YEMEN | $6.2K | 3 | 5.2% |
| SRI LANKA | $4.3K | 1 | 3.6% |
| UNITED STATES | $1.7K | 3 | 1.4% |
| AFGHANISTAN | $770 | 2 | 0.6% |
GLS Pharma Limited exports Cyclophosphamide to 5 countries. The largest destination is MEXICO accounting for 89.2% of GLS Pharma Limited's Cyclophosphamide shipments, followed by YEMEN (5.2%) and SRI LANKA (3.6%). These destinations reflect GLS Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cyclophosphamide from GLS Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CALLEX MEDICAMENTOS S. DE RL DE CV | MEXICO | $88.1K | 19 |
| CALLEX MEDICAMENTOS S DE RL DE | MEXICO | $19.2K | 4 |
| ALFWASEL FOR GENERAL TRADING | YEMEN | $6.2K | 3 |
| STATE PHARMACEUTICALS | SRI LANKA | $4.3K | 1 |
| HOOP PHARMA LLC | UNITED STATES | $1.7K | 3 |
| REAL LINE PHARMA | AFGHANISTAN | $770 | 2 |
GLS Pharma Limited supplies Cyclophosphamide to 6 buyers globally. The largest buyer is CALLEX MEDICAMENTOS S. DE RL DE CV (MEXICO), followed by CALLEX MEDICAMENTOS S DE RL DE (MEXICO) and ALFWASEL FOR GENERAL TRADING (YEMEN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cyclophosphamide Export Value and How Much Does GLS Pharma Limited Contribute?
India exported $4.6M worth of Cyclophosphamide through 2,113 shipments from 259 suppliers to 114 countries, serving 518 buyers globally. GLS Pharma Limited contributes $120.3K to this total, accounting for 0.6% of India's Cyclophosphamide exports. GLS Pharma Limited ships Cyclophosphamide to 5 countries through 6 buyers.
What Is the Average Shipment Value for GLS Pharma Limited's Cyclophosphamide Exports?
GLS Pharma Limited's average Cyclophosphamide shipment value is $3.8K per consignment, based on 32 shipments totaling $120.3K. The largest destination is MEXICO (89.2% of GLS Pharma Limited's Cyclophosphamide exports).
How Does GLS Pharma Limited Compare to Other Indian Cyclophosphamide Exporters?
GLS Pharma Limited ranks #12 among 259 Indian Cyclophosphamide exporters with a 0.6% market share. The top 3 exporters are EUGIA PHARMA SPECIALITIES LIMITED ($1.1M), ALEMBIC PHARMACEUTICALS LIMITED ($850.4K), CIPLA LIMITED ($550.0K). GLS Pharma Limited processed 32 shipments to 5 destination countries.
What Cyclophosphamide Formulations Does GLS Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PONFECYC 200MG INJECTION (CYCLOPHOSPHAMIDE FOR INJECTION 200MG/VIAL)VLS | $52.4K | 11 |
| PONFECYC 500MG INJECTION (CYCLOPHOSPHAMIDE FOR INJECTION 500MG/VIAL)VLS | $35.7K | 8 |
| PONFECYC 500MG INJECTION CYCLOPHOSPHAMIDE FOR INJECTION 500MG/VIAL | $19.2K | 4 |
| Cyclophosphamide 200 mg inj | $4.3K | 1 |
| CYCLOPHOSPHAMIDE 1000 MG INJ (BRAND CTX-GLS) | $3.9K | 1 |
| CYCLOPHOSPHAMIDE 500 MG INJ (BRAND CTX-GLS) | $2.1K | 1 |
| CTX-GLS 1GM INJECTION (Cyclophosphamide | $805 | 1 |
| CTX GLS 1GM INJ (CYCLOPHOSPHAMIDE 1000MG INJ) BATCH NO CYPC2417G MFGDT APR-24 EXP DT MAR-26 | $655 | 1 |
| CTX-GLS 500MG (Cyclophosphamide 500mg in | $607 | 1 |
| CTX-GLS 200MG (Cyclophosphamide 200mg in | $297 | 1 |
GLS Pharma Limited exports 12 distinct Cyclophosphamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PONFECYC 200MG INJECTION (CYCLOPHOSPHAMIDE FOR INJECTION 200 with 11 shipments worth $52.4K.
Regulatory Requirements: Exporting Cyclophosphamide to Key Markets
What GLS Pharma Limited must comply with to export Cyclophosphamide to its top destination countries
Mexico — COFEPRIS
Approval Process
Generic registration under Mexican health law. NOM standards apply.
Timeline: 12–18 months
GMP & Export Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Sanitary Import Permit from COFEPRIS; import licence via SAT
Note: COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does GLS Pharma Limited Compare to Nearest Cyclophosphamide Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | VIVALIA REMEDIES PRIVATE LIMITED | $147.8K | 4 | 1 | $37.0K |
| 11 | GETWELL PHARMA INDIA PRIVATE LIMITED | $139.9K | 71 | 13 | $2.0K |
| 12 | GLS PHARMA LIMITED ★ | $120.3K | 32 | 5 | $3.8K |
| 13 | UNITED BIOTECH PRIVATE LIMITED | $110.4K | 75 | 9 | $1.5K |
GLS Pharma Limited ranks #12 among 259 Indian Cyclophosphamide exporters. Average shipment value of $3.8K compared to the market average of $17.9K. The closest competitors by value are VIVALIA REMEDIES PRIVATE LIMITED and GETWELL PHARMA INDIA PRIVATE LIMITED.
Which Indian Ports Ship Cyclophosphamide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 561 | 26.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 442 | 20.9% |
| DELHI AIR | 246 | 11.6% |
| DELHI AIR CARGO ACC (INDEL4) | 189 | 8.9% |
| Bombay Air | 154 | 7.3% |
| Delhi Air | 51 | 2.4% |
| Bombay Air Cargo | 51 | 2.4% |
| HYDERABAD AIR | 36 | 1.7% |
About GLS Pharma Limited
GLS Pharma Limited exports 4 products worth $198.8K. Beyond Cyclophosphamide, top products include Ifosfamide, Busulfan, Chlorambucil. View the complete GLS Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cyclophosphamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cyclophosphamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: GLS Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 32 individual customs records matching GLS Pharma Limited exporting Cyclophosphamide, covering 12 formulations to 5 countries via 6 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 114+ countries, 518+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cyclophosphamide Export Data from GLS Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for GLS Pharma Limited's Cyclophosphamide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
GLS Pharma Limited
Full Company Profile →
4 products · $198.8K total trade · 2 categories
Cyclophosphamide Stats
Company Overview
Top Products by GLS Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for GLS Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cyclophosphamide. For current shipment-level data, contact TransData Nexus.